Skip to main content
Metal-Based Drugs logoLink to Metal-Based Drugs
. 1994;1(2-3):241–246. doi: 10.1155/MBD.1994.241

Multinuclear Metal Nucleobase Complexes

A Schreiber 1,, H Rauter 1, M Krumm 1, S Menzer 1, E C Hillgeris 1, B Lippert 1
PMCID: PMC2364887  PMID: 18476236

Abstract

Of all properties of metal nucleobase complexes, formation of multinuclear species appears to be an outstanding feature. After a brief introduction into well known polymeric metal nucleobase complexes, three aspects recently Studied in our laboratory will be dealt with in more detail: (i) Heteronuclear complexes derived from trans-[(amine)2Pt(1-MeC)2]2+ (1-MeC=1-methylcytosine). They form, e. g. with Pd(II) or Hg(II), upon single deprotonation of the exocyclic amino group of each 1-MeC ligand, compounds of type trans-[(amine)2Pt(1-MeC-)2MY]n+, displaying Pt-M bond formation. (ii) Cyclic nucleobase complexes derived from cis-a2Pt(II). A cyclic compound of composition {[(en)Pt(UH-N1,N3)]4}4+ (UH=monoanion of unsubstituted uracil) is presented and the analogy with organic calix-[4]-arenes is pointed out. (iii) Cyclic nucleobase complexes from trans-a2Pt(II). Possible ways for the preparation of macrocyclic nucleobase complexes containing trans-a2Pt(II) linkages are outlined and precursors and intermediates are presented.

Full Text

The Full Text of this article is available as a PDF (654.3 KB).


Articles from Metal-Based Drugs are provided here courtesy of Wiley

RESOURCES